Publications by authors named "Margreet Ausems"

Claim this Profile
E
Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway.
Michiel Vlaming, Eveline M A Bleiker, Gina Schijven, Lambertus A L M Kiemeney, Harm H E van Melick, Margreet G E M Ausems

Int J Cancer· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer.
Michiel Vlaming, Wouter Koole, R Jeroen A van Moorselaar, Eveline M A Bleiker, Ellen van de Geer, Margreet G E M Ausems

BJU Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on bone mineral density.
Maarten J Beekman, Lara Terra, Anniek Stuursma, Bernadette A M Heemskerk-Gerritsen, Jeanine E Roeters van Lennep, Margreet G E M Ausems

Osteoporos Int· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Barriers and facilitators for medical oncologists in the further implementation of mainstream genetic testing in breast cancer care in the Netherlands.
Chiem L de Jong, Gina Schijven, Ellen G Engelhardt, Agnes Jager, Margreet G E M Ausems

Fam Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variant.
Maartje A C Schreurs, Muriel A Adank, Bernadette A M Heemskerk-Gerritsen, Antoinette Hollestelle, Nyrée Smallenbroek, Margreet G E M Ausems

Breast· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers and facilitators for medical oncologists in the further implementation of mainstream genetic testing in breast cancer care in the Netherlands.
Chiem L de Jong, Gina Schijven, Ellen G Engelhardt, Agnes Jager, Margreet G E M Ausems

Fam Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer.
Michiel Vlaming, Margreet G E M Ausems, Lambertus A L M Kiemeney, Gina Schijven, Harm H E van Melick

Prostate Cancer Prostatic Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide implementation and evaluation of the Tumor-First workflow for genetic testing in ovarian carcinoma.
Vera M Witjes, Joanne A de Hullu, Dorien M A Hermkens, Yvonne H C M Smolders, Julie E M Swillens, Margreet G E M Ausems

Int J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of a mainstream genetic testing pathway and socioeconomic factors on the uptake of germline genetic testing in breast cancer patients: results of the nationwide GENE-SMART study.
Chiem Leonardo de Jong, Sabine Siesling, Ghita Carola Wilhelmina Maria Puts, Agnes Jager, Margreet Geertruda Elia Maria Ausems

Breast Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Dutch citizens' perspectives, expectations, and decision-making regarding health-related direct-to-consumer genetic testing (DTC-GT).
Danny Bruins, Suzanne M Onstwedder, Martina C Cornel, Marc H W van Mil, Margreet G E M Ausems

Public Health Genomics· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No increased arterial stiffness after premenopausal risk-reducing salpingo-oophorectomy (RRSO).
Maarten J Beekman, Lara Terra, Jeanine E Roeters van Lennep, Bernadette A M Heemskerk-Gerritsen, Marc van Beurden, Margreet G E M Ausems

Maturitas· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers.
Iris A S Stroot, Joost Bart, Harry Hollema, Marise M Wagner, Refika Yigit, Margreet G E M Ausems

J Natl Cancer Inst· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary Artery Calcium Scores After Prophylactic Premenopausal Bilateral Salpingo-Oophorectomy.
Maarten J Beekman, Lara Terra, Bernadette A M Heemskerk-Gerritsen, Carlijn M van der Aalst, Jeanine E Roeters van Lennep, Margreet G E M Ausems

JACC CardioOncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow.
Vera M Witjes, Dorien M A Hermkens, Julie E M Swillens, Yvonne H C M Smolders, Marian J E Mourits, Margreet G E M Ausems

Fam Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort profile: a nationwide study in Dutch c.1100delC families using the infrastructure of the HEreditary Breast and Ovarian cancer study Netherlands - Hebon-CHEK2.
Maartje A C Schreurs, Muriel A Adank, Antoinette Hollestelle, Rosa de Groot, Denise J Stommel-Jenner, Margreet G E M Ausems

BMJ Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.
Maartje A C Schreurs, Marjanka K Schmidt, Antoinette Hollestelle, Michael Schaapveld, Christi J van Asperen, Margreet G E M Ausems

Genet Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers.
Iris A S Stroot, Joost Bart, Harry Hollema, Mathilde Jalving, Marise M Wagner, Margreet G E M Ausems

Gynecol Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the BOADICEA model in a prospective cohort of pathogenic variant carriers.
Xin Yang, Thea M Mooij, Goska Leslie, Lorenzo Ficorella, Nadine Andrieu, Margreet G E M Ausems

J Med Genet· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relatives.
Michiel Vlaming, Margreet G E M Ausems, Gina Schijven, Inge M van Oort, C Marleen Kets

Fam Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Information Provision Regarding Health-Related Direct-to-Consumer Genetic Testing for Dutch Consumers: An in-Depth Content Analysis of Sellers' Websites.
Danny Bruins, Suzanne M Onstwedder, Martina C Cornel, Margreet G E M Ausems, Marc H W van Mil

Genes (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy Risk.
Kasper A Overbeek, Brechtje D M Koopmann, Iris J M Levink, Matteo Tacelli, Nicole S Erler, Margreet G E Ausems

Clin Gastroenterol Hepatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary incontinence more than 15 years after premenopausal risk-reducing salpingo-oophorectomy: a multicentre cross-sectional study.
Lara Terra, Bernadette A M Heemskerk-Gerritsen, Maarten J Beekman, Ellen Engelhardt, Marian J E Mourits, Margreet G E M Ausems

BJOG· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.
Mark van Barele, Delal Akdeniz, Bernadette A M Heemskerk-Gerritsen, , Nadine Andrieu, Margreet G E M Ausems

J Natl Cancer Inst· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The most efficient and effective BRCA1/2 testing strategy in epithelial ovarian cancer: Tumor-First or Germline-First?
Vera M Witjes, Marjolijn J L Ligtenberg, Janet R Vos, Jozé C C Braspenning, Margreet G E M Ausems

Gynecol Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.
Karin Kast, Esther M John, John L Hopper, Nadine Andrieu, Catherine Noguès, Margreet G E M Ausems

Breast Cancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis